Antibodies to SARS-CoV-2 and risk of past or future sick leave

Antibodies to SARS-CoV-2 and risk of past or future sick leave

Abstract The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease is unknown. We invited all employees (n = 15,300) at work at the Karolinska University Hospital, Stockholm, Sweden to participate in a study examining SARS-Cov-2 antibodies in relation to registered...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joakim Dillner, K. Miriam Elfström, Jonas Blomqvist, Carina Eklund, Camilla Lagheden, Sara Nordqvist-Kleppe, Cecilia Hellström, Jennie Olofsson, Eni Andersson, August Jernbom Falk, Sofia Bergström, Emilie Hultin, Elisa Pin, Anna Månberg, Peter Nilsson, My Hedhammar, Sophia Hober, Johan Mattsson, Laila Sara Arroyo Mühr, Kalle Conneryd Lundgren
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/a12aa03869c945dba2214b88c4d4805c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares